Outcome of surgical treatment of liver metastasis from colorectal cancer

被引:0
|
作者
Norero, Enrique
Jarufe, Nicolas [1 ]
Butte, Jean M.
Norero, Blanca
Duarte, Ignacio [2 ]
Torres, Javiera [2 ]
Pinedo, George
Lopez, Francisco
Francisco Guerra, Juan
Ibanez, Luis
Zuniga, Alvaro
Guzman, Sergio
Martinez, Jorge
机构
[1] Pontificia Univ Catolica Chile, Fac Med, Dept Cirugia Digest, Div Cirugia, Santiago, Chile
[2] Pontificia Univ Catolica Chile, Fac Med, Dept Anat Patol, Santiago, Chile
关键词
Colorectal neoplasms; Neoplasm metastasis; Survival; HEPATIC RESECTION; CARCINOMA METASTASES; FLUOROURACIL; LEUCOVORIN; IRINOTECAN; CHEMOTHERAPY; OXALIPLATIN; SURVIVAL; SURGERY; THERAPY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Surgical resection is the only treatment associated with long-term curve in patients with liver metastasis from colorectal cancer, achieving a 30% to 40% five years survival. Aim: To evaluate the results of liver resection for metastatic colorectal cancer in our centre. Patients and methods: Retrospective study, Epidemiological, perioperative and follow up data of patients undergoing liver resection for metastatic colorectal cancer between January 1990 and July 2007 were assessed. We compared the results between two periods; period 1 (1990-1997) and period 2 (1998-2007). Results: Sixty six patients aged 61 +/- 12 years (46 males) underwent 75 resections. An anatomical excision was performed in 54 (72%) cases , a right hapatectomy in 18, an extended right hepatectomy in 11, a left hepatectomy in 1, and a segmentectomy in 24. In 24 (32%) patients the liver resection was simultaneous with the colorectal cancer resection. Operative time was 221 +/- 86 min. Hospital stay was 11 +/- 5 days. Postoperative morbidity was 35% and surgical mortality was 0%. Resection margin was free of tumor in 53 (80%) patients. Five years overall and hepatic disease-free survival was 38% and 23%, respectively. In period 2, more anatomical resections than in period 1 were performed (77% and 55%, respectively, p = 0.04), without an increase in complications (35% and 34%, respectively; p = ns), but with a better five years survival (45% and 21% respectively, p = 0.04). Conclusions: Five years survival for excision of liver metastatic colorectal cancer in our center is similar to that reported abroad. During the second period there has been a trend toward more extensive resections which was associated with a better survival, without an increase in complications or mortality (Rev Med Chile 2009; 137: 487-96).
引用
收藏
页码:487 / 496
页数:10
相关论文
共 50 条
  • [1] Perioperative chemotherapy with bevacizumab and liver resection for colorectal cancer liver metastasis
    Chaudhury, Prosanto
    Hassanain, Mazen
    Bouganim, Nathaniel
    Salman, Ayat
    Kavan, Petr
    Metrakos, Peter
    HPB, 2010, 12 (01) : 37 - 42
  • [2] Surgical treatment of liver metastasis in patients with colorectal cancer
    Chirica, Mircea
    Leconte, Mahaut
    Oberlin, Olivier
    Dousset, Bertrand
    PRESSE MEDICALE, 2012, 41 (01): : 58 - 67
  • [3] Surgical treatment of ovarian cancer liver metastasis
    Wang, Miao
    Zhou, Jiamin
    Zhang, Lyu
    Zhao, Yiming
    Zhang, Ning
    Wang, Longrong
    Zhu, Weiping
    He, Xigan
    Zhu, Hongxu
    Xu, Weiqi
    Pan, Qi
    Mao, Anrong
    Li, Qinchuan
    Wang, Lu
    HEPATOBILIARY SURGERY AND NUTRITION, 2019, 8 (02) : 129 - 137
  • [4] A prognostic indicator for the resection of liver metastasis of colorectal cancer
    Amano, Ryosuke
    Yamada, Nobuya
    Nakata, Bunzo
    Kimura, Kenjiro
    Yashiro, Masakazu
    Ohira, Masaichi
    Hirakawa, Kosei
    SURGERY TODAY, 2014, 44 (07) : 1287 - 1292
  • [5] Surgical Outcome and Prognostic Stratification for Pulmonary Metastasis From Colorectal Cancer
    Okumura, Takehiro
    Boku, Narikazu
    Hishida, Tomoyuki
    Ohde, Yasuhisa
    Sakao, Yukinori
    Yoshiya, Katsuo
    Higashiyama, Masahiko
    Hyodo, Ichinosuke
    Mori, Keita
    Kondo, Haruhiko
    ANNALS OF THORACIC SURGERY, 2017, 104 (03) : 979 - 987
  • [6] Hepatectomy for liver metastasis of colorectal cancer
    Xu, Jianmin
    Wei, Ye
    Zhong, Yunshi
    Fan, Jia
    Zhou, Jian
    Qin, Lunxiu
    Ren, Li
    Qin, Xinyu
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2009, 24 (04) : 419 - 425
  • [7] Treatment strategy for resectable colorectal cancer liver metastases from the viewpoint of time to surgical failure
    Hirokawa, Fumitoshi
    Ueno, Masaki
    Nakai, Takuya
    Kaibori, Masaki
    Nomi, Takeo
    Iida, Hiroya
    Tanaka, Shogo
    Komeda, Koji
    Hayami, Shinya
    Kosaka, Hisashi
    Hokuto, Daisuke
    Kubo, Shoji
    Uchiyama, Kazuhisa
    LANGENBECKS ARCHIVES OF SURGERY, 2022, 407 (02) : 699 - 706
  • [8] Therapeutic Strategy of Colorectal Liver Metastasis Using Modified-JHBPS Nomogram
    Kubo, Hidemasa
    Ikoma, Hisashi
    Yamamoto, Yusuke
    Morimura, Ryo
    Kiuchi, Jun
    Shimizu, Hiroki
    Arita, Tomohiro
    Kuriu, Yoshiaki
    Okamoto, Kazuma
    Otsuji, Eigo
    ANTICANCER RESEARCH, 2021, 41 (07) : 3657 - 3665
  • [9] Implications of clinical risk score to predict outcomes of liver-confined metastasis of colorectal cancer
    Shin, Sang Joon
    Ahn, Joong Bae
    Choi, Jin Sub
    Choi, Gi-Hong
    Lee, Kang Young
    Baik, Seung Hyuk
    Min, Byung Soh
    Hur, Hyuk
    Roh, Jae Kyung
    Kim, Nam Kyu
    SURGICAL ONCOLOGY-OXFORD, 2012, 21 (03): : E125 - E130
  • [10] Outcome after repeat resection of liver metastases from colorectal cancer
    Neeff, Hannes P.
    Drognitz, Oliver
    Holzner, Philipp
    Klock, Andrea
    Bronsert, Peter
    Hopt, Ulrich T.
    Makowiec, Frank
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2013, 28 (08) : 1135 - 1141